Typically, autoantibodies targeting MDA5, Mi‐2, SAE, NXP2 and TIF1γ are associated with DM; autoantibodies against tRNA synthetases (such as Jo1, PL‐7, PL‐12 and EJ) are linked to ASS; and autoantibodies targeting SRP and HMGCR are identified in IMNM [1]. This evidence concerns the gene MORC3 and dermatomyositis.